Quick Asked: Myricx Pharma Ltd Contact Us?
Last update: 04 May, 2024 
104 Views
How do i get in contact with pediatrix medical group? If you are interested in learning more about our clinical outsourcing solutions or want to initiate an RFP for Pediatrix Medical Group, please submit your contact information using the following form or call 855.5.MEDNAX (855.563.3629). A representative will contact you within 24 hours.What is medix pharmacy? Medix Pharmacy is a prescription referral service that works with licensed pharmacy partners in the UK, Canada, New Zealand and Australia. We hope you benefit from the improved service now delivered through our new website, www.MedixRx.com. Find the lowest price on:How do i contact mednax? If you are a member of a private group practice interested in exploring the many benefits of joining our national medical group, please submit your contact information using the following form or call 855.5.MEDNAX (855.563.3629).Why choose matrixmatrix distributors? Matrix Distributors, Inc. is the optimal choice for your independent pharmacy's growth and success.
Listing Results Myricx Pharma Ltd Contact Us? Question Answers
New investments for drug research Brandon Capital
November 17, 2020. Brandon Capital, Sofinnova Partners invest $8.2 m in new UK start-up seeking novel cancer blocker. The Medical Research Commercialisation Fund and European venture capital firm, Sofinnova Partners, have co-led an initial investment of $8.2 million (£4.5 million) into Myricx Pharma, a new drug discovery company focused on developing ...
Myricx Pharma Limited Company Profile Endole
Myricx Pharma Limited is an active company incorporated on 3 July 2019 with the registered office located in Stevenage, Hertfordshire. Myricx Pharma Limited has been running for 1 year 7 months. There are currently 4 active directors and 1 active secretary according to the latest confirmation statement submitted on 2nd July 2020.
Myricx Pharma – Brandon Capital Partners
Myricx Pharma (“Myricx”) is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across viral and other diseases. Myricx operates from the Stevenage Bioscience Catalyst facility, UK, and was founded in 2019 based ...